Global Tuberculosis Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tuberculosis Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Tuberculosis Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Tuberculosis Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Tuberculosis Vaccines Segment by Type

2.2.1 Immunotherapeutic Vaccines

2.2.2 Booster Vaccines

2.2.3 Others

2.3 Tuberculosis Vaccines Sales by Type

2.3.1 Global Tuberculosis Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Tuberculosis Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Tuberculosis Vaccines Sale Price by Type (2017-2022)

2.4 Tuberculosis Vaccines Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Tuberculosis Vaccines Sales by Application

2.5.1 Global Tuberculosis Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Tuberculosis Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Tuberculosis Vaccines Sale Price by Application (2017-2022)

3 Global Tuberculosis Vaccines by Company

3.1 Global Tuberculosis Vaccines Breakdown Data by Company

3.1.1 Global Tuberculosis Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Tuberculosis Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Tuberculosis Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Tuberculosis Vaccines Revenue by Company (2020-2022)

3.2.2 Global Tuberculosis Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Tuberculosis Vaccines Sale Price by Company

3.4 Key Manufacturers Tuberculosis Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Tuberculosis Vaccines Product Location Distribution

3.4.2 Players Tuberculosis Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Tuberculosis Vaccines by Geographic Region

4.1 World Historic Tuberculosis Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Tuberculosis Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Tuberculosis Vaccines Annual Revenue by Geographic Region

4.2 World Historic Tuberculosis Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Tuberculosis Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Tuberculosis Vaccines Annual Revenue by Country/Region

4.3 Americas Tuberculosis Vaccines Sales Growth

4.4 APAC Tuberculosis Vaccines Sales Growth

4.5 Europe Tuberculosis Vaccines Sales Growth

4.6 Middle East & Africa Tuberculosis Vaccines Sales Growth

5 Americas

5.1 Americas Tuberculosis Vaccines Sales by Country

5.1.1 Americas Tuberculosis Vaccines Sales by Country (2017-2022)

5.1.2 Americas Tuberculosis Vaccines Revenue by Country (2017-2022)

5.2 Americas Tuberculosis Vaccines Sales by Type

5.3 Americas Tuberculosis Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tuberculosis Vaccines Sales by Region

6.1.1 APAC Tuberculosis Vaccines Sales by Region (2017-2022)

6.1.2 APAC Tuberculosis Vaccines Revenue by Region (2017-2022)

6.2 APAC Tuberculosis Vaccines Sales by Type

6.3 APAC Tuberculosis Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Tuberculosis Vaccines by Country

7.1.1 Europe Tuberculosis Vaccines Sales by Country (2017-2022)

7.1.2 Europe Tuberculosis Vaccines Revenue by Country (2017-2022)

7.2 Europe Tuberculosis Vaccines Sales by Type

7.3 Europe Tuberculosis Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tuberculosis Vaccines by Country

8.1.1 Middle East & Africa Tuberculosis Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Tuberculosis Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Tuberculosis Vaccines Sales by Type

8.3 Middle East & Africa Tuberculosis Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccines

10.3 Manufacturing Process Analysis of Tuberculosis Vaccines

10.4 Industry Chain Structure of Tuberculosis Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Tuberculosis Vaccines Distributors

11.3 Tuberculosis Vaccines Customer

12 World Forecast Review for Tuberculosis Vaccines by Geographic Region

12.1 Global Tuberculosis Vaccines Market Size Forecast by Region

12.1.1 Global Tuberculosis Vaccines Forecast by Region (2023-2028)

12.1.2 Global Tuberculosis Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Tuberculosis Vaccines Forecast by Type

12.7 Global Tuberculosis Vaccines Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Tuberculosis Vaccines Product Offered

13.1.3 Sanofi Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Tuberculosis Vaccines Product Offered

13.2.3 Merck Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Serum Institute of India

13.3.1 Serum Institute of India Company Information

13.3.2 Serum Institute of India Tuberculosis Vaccines Product Offered

13.3.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Serum Institute of India Main Business Overview

13.3.5 Serum Institute of India Latest Developments

13.4 GlaxoSmithKline

13.4.1 GlaxoSmithKline Company Information

13.4.2 GlaxoSmithKline Tuberculosis Vaccines Product Offered

13.4.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GlaxoSmithKline Main Business Overview

13.4.5 GlaxoSmithKline Latest Developments

13.5 Japan BCG Lab

13.5.1 Japan BCG Lab Company Information

13.5.2 Japan BCG Lab Tuberculosis Vaccines Product Offered

13.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Japan BCG Lab Main Business Overview

13.5.5 Japan BCG Lab Latest Developments

13.6 IDT Biologics

13.6.1 IDT Biologics Company Information

13.6.2 IDT Biologics Tuberculosis Vaccines Product Offered

13.6.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 IDT Biologics Main Business Overview

13.6.5 IDT Biologics Latest Developments

13.7 GreenSignal Bio Pharma

13.7.1 GreenSignal Bio Pharma Company Information

13.7.2 GreenSignal Bio Pharma Tuberculosis Vaccines Product Offered

13.7.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 GreenSignal Bio Pharma Main Business Overview

13.7.5 GreenSignal Bio Pharma Latest Developments

13.8 Taj Pharmaceuticals

13.8.1 Taj Pharmaceuticals Company Information

13.8.2 Taj Pharmaceuticals Tuberculosis Vaccines Product Offered

13.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Taj Pharmaceuticals Main Business Overview

13.8.5 Taj Pharmaceuticals Latest Developments

13.9 Bavarian Nordic

13.9.1 Bavarian Nordic Company Information

13.9.2 Bavarian Nordic Tuberculosis Vaccines Product Offered

13.9.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bavarian Nordic Main Business Overview

13.9.5 Bavarian Nordic Latest Developments

13.10 China National Biotec Group

13.10.1 China National Biotec Group Company Information

13.10.2 China National Biotec Group Tuberculosis Vaccines Product Offered

13.10.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 China National Biotec Group Main Business Overview

13.10.5 China National Biotec Group Latest Developments

14 Research Findings and Conclusion

Table 1. Tuberculosis Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Tuberculosis Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Immunotherapeutic Vaccines

Table 4. Major Players of Booster Vaccines

Table 5. Major Players of Others

Table 6. Global Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)

Table 7. Global Tuberculosis Vaccines Sales Market Share by Type (2017-2022)

Table 8. Global Tuberculosis Vaccines Revenue by Type (2017-2022) & ($ million)

Table 9. Global Tuberculosis Vaccines Revenue Market Share by Type (2017-2022)

Table 10. Global Tuberculosis Vaccines Sale Price by Type (2017-2022) & (USD/Dose)

Table 11. Global Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)

Table 12. Global Tuberculosis Vaccines Sales Market Share by Application (2017-2022)

Table 13. Global Tuberculosis Vaccines Revenue by Application (2017-2022)

Table 14. Global Tuberculosis Vaccines Revenue Market Share by Application (2017-2022)

Table 15. Global Tuberculosis Vaccines Sale Price by Application (2017-2022) & (USD/Dose)

Table 16. Global Tuberculosis Vaccines Sales by Company (2020-2022) & (K Doses)

Table 17. Global Tuberculosis Vaccines Sales Market Share by Company (2020-2022)

Table 18. Global Tuberculosis Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Tuberculosis Vaccines Revenue Market Share by Company (2020-2022)

Table 20. Global Tuberculosis Vaccines Sale Price by Company (2020-2022) & (USD/Dose)

Table 21. Key Manufacturers Tuberculosis Vaccines Producing Area Distribution and Sales Area

Table 22. Players Tuberculosis Vaccines Products Offered

Table 23. Tuberculosis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Tuberculosis Vaccines Sales by Geographic Region (2017-2022) & (K Doses)

Table 27. Global Tuberculosis Vaccines Sales Market Share Geographic Region (2017-2022)

Table 28. Global Tuberculosis Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Tuberculosis Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Tuberculosis Vaccines Sales by Country/Region (2017-2022) & (K Doses)

Table 31. Global Tuberculosis Vaccines Sales Market Share by Country/Region (2017-2022)

Table 32. Global Tuberculosis Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Tuberculosis Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Tuberculosis Vaccines Sales by Country (2017-2022) & (K Doses)

Table 35. Americas Tuberculosis Vaccines Sales Market Share by Country (2017-2022)

Table 36. Americas Tuberculosis Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Tuberculosis Vaccines Revenue Market Share by Country (2017-2022)

Table 38. Americas Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)

Table 39. Americas Tuberculosis Vaccines Sales Market Share by Type (2017-2022)

Table 40. Americas Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)

Table 41. Americas Tuberculosis Vaccines Sales Market Share by Application (2017-2022)

Table 42. APAC Tuberculosis Vaccines Sales by Region (2017-2022) & (K Doses)

Table 43. APAC Tuberculosis Vaccines Sales Market Share by Region (2017-2022)

Table 44. APAC Tuberculosis Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Tuberculosis Vaccines Revenue Market Share by Region (2017-2022)

Table 46. APAC Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)

Table 47. APAC Tuberculosis Vaccines Sales Market Share by Type (2017-2022)

Table 48. APAC Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)

Table 49. APAC Tuberculosis Vaccines Sales Market Share by Application (2017-2022)

Table 50. Europe Tuberculosis Vaccines Sales by Country (2017-2022) & (K Doses)

Table 51. Europe Tuberculosis Vaccines Sales Market Share by Country (2017-2022)

Table 52. Europe Tuberculosis Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Tuberculosis Vaccines Revenue Market Share by Country (2017-2022)

Table 54. Europe Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)

Table 55. Europe Tuberculosis Vaccines Sales Market Share by Type (2017-2022)

Table 56. Europe Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)

Table 57. Europe Tuberculosis Vaccines Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Tuberculosis Vaccines Sales by Country (2017-2022) & (K Doses)

Table 59. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Tuberculosis Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Tuberculosis Vaccines Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Tuberculosis Vaccines Sales by Type (2017-2022) & (K Doses)

Table 63. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Tuberculosis Vaccines Sales by Application (2017-2022) & (K Doses)

Table 65. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Tuberculosis Vaccines

Table 67. Key Market Challenges & Risks of Tuberculosis Vaccines

Table 68. Key Industry Trends of Tuberculosis Vaccines

Table 69. Tuberculosis Vaccines Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Tuberculosis Vaccines Distributors List

Table 72. Tuberculosis Vaccines Customer List

Table 73. Global Tuberculosis Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 74. Global Tuberculosis Vaccines Sales Market Forecast by Region

Table 75. Global Tuberculosis Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Tuberculosis Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Tuberculosis Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 78. Americas Tuberculosis Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Tuberculosis Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 80. APAC Tuberculosis Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Tuberculosis Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 82. Europe Tuberculosis Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Tuberculosis Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 84. Middle East & Africa Tuberculosis Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Tuberculosis Vaccines Sales Forecast by Type (2023-2028) & (K Doses)

Table 86. Global Tuberculosis Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Tuberculosis Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Tuberculosis Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Tuberculosis Vaccines Sales Forecast by Application (2023-2028) & (K Doses)

Table 90. Global Tuberculosis Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Tuberculosis Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Tuberculosis Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 93. Sanofi Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 94. Sanofi Tuberculosis Vaccines Product Offered

Table 95. Sanofi Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 96. Sanofi Main Business

Table 97. Sanofi Latest Developments

Table 98. Merck Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 99. Merck Tuberculosis Vaccines Product Offered

Table 100. Merck Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 101. Merck Main Business

Table 102. Merck Latest Developments

Table 103. Serum Institute of India Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 104. Serum Institute of India Tuberculosis Vaccines Product Offered

Table 105. Serum Institute of India Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 106. Serum Institute of India Main Business

Table 107. Serum Institute of India Latest Developments

Table 108. GlaxoSmithKline Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 109. GlaxoSmithKline Tuberculosis Vaccines Product Offered

Table 110. GlaxoSmithKline Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 111. GlaxoSmithKline Main Business

Table 112. GlaxoSmithKline Latest Developments

Table 113. Japan BCG Lab Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 114. Japan BCG Lab Tuberculosis Vaccines Product Offered

Table 115. Japan BCG Lab Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 116. Japan BCG Lab Main Business

Table 117. Japan BCG Lab Latest Developments

Table 118. IDT Biologics Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 119. IDT Biologics Tuberculosis Vaccines Product Offered

Table 120. IDT Biologics Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 121. IDT Biologics Main Business

Table 122. IDT Biologics Latest Developments

Table 123. GreenSignal Bio Pharma Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 124. GreenSignal Bio Pharma Tuberculosis Vaccines Product Offered

Table 125. GreenSignal Bio Pharma Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 126. GreenSignal Bio Pharma Main Business

Table 127. GreenSignal Bio Pharma Latest Developments

Table 128. Taj Pharmaceuticals Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 129. Taj Pharmaceuticals Tuberculosis Vaccines Product Offered

Table 130. Taj Pharmaceuticals Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 131. Taj Pharmaceuticals Main Business

Table 132. Taj Pharmaceuticals Latest Developments

Table 133. Bavarian Nordic Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 134. Bavarian Nordic Tuberculosis Vaccines Product Offered

Table 135. Bavarian Nordic Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 136. Bavarian Nordic Main Business

Table 137. Bavarian Nordic Latest Developments

Table 138. China National Biotec Group Basic Information, Tuberculosis Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 139. China National Biotec Group Tuberculosis Vaccines Product Offered

Table 140. China National Biotec Group Tuberculosis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 141. China National Biotec Group Main Business

Table 142. China National Biotec Group Latest Developments

List of Figures

Figure 1. Picture of Tuberculosis Vaccines

Figure 2. Tuberculosis Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Tuberculosis Vaccines Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Tuberculosis Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Tuberculosis Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Immunotherapeutic Vaccines

Figure 10. Product Picture of Booster Vaccines

Figure 11. Product Picture of Others

Figure 12. Global Tuberculosis Vaccines Sales Market Share by Type in 2021

Figure 13. Global Tuberculosis Vaccines Revenue Market Share by Type (2017-2022)

Figure 14. Tuberculosis Vaccines Consumed in Hospitals

Figure 15. Global Tuberculosis Vaccines Market: Hospitals (2017-2022) & (K Doses)

Figure 16. Tuberculosis Vaccines Consumed in Clinics

Figure 17. Global Tuberculosis Vaccines Market: Clinics (2017-2022) & (K Doses)

Figure 18. Tuberculosis Vaccines Consumed in Others

Figure 19. Global Tuberculosis Vaccines Market: Others (2017-2022) & (K Doses)

Figure 20. Global Tuberculosis Vaccines Sales Market Share by Application (2017-2022)

Figure 21. Global Tuberculosis Vaccines Revenue Market Share by Application in 2021

Figure 22. Tuberculosis Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Tuberculosis Vaccines Revenue Market Share by Company in 2021

Figure 24. Global Tuberculosis Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Tuberculosis Vaccines Revenue Market Share by Geographic Region in 2021

Figure 26. Global Tuberculosis Vaccines Sales Market Share by Region (2017-2022)

Figure 27. Global Tuberculosis Vaccines Revenue Market Share by Country/Region in 2021

Figure 28. Americas Tuberculosis Vaccines Sales 2017-2022 (K Doses)

Figure 29. Americas Tuberculosis Vaccines Revenue 2017-2022 ($ Millions)

Figure 30. APAC Tuberculosis Vaccines Sales 2017-2022 (K Doses)

Figure 31. APAC Tuberculosis Vaccines Revenue 2017-2022 ($ Millions)

Figure 32. Europe Tuberculosis Vaccines Sales 2017-2022 (K Doses)

Figure 33. Europe Tuberculosis Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Tuberculosis Vaccines Sales 2017-2022 (K Doses)

Figure 35. Middle East & Africa Tuberculosis Vaccines Revenue 2017-2022 ($ Millions)

Figure 36. Americas Tuberculosis Vaccines Sales Market Share by Country in 2021

Figure 37. Americas Tuberculosis Vaccines Revenue Market Share by Country in 2021

Figure 38. United States Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Tuberculosis Vaccines Sales Market Share by Region in 2021

Figure 43. APAC Tuberculosis Vaccines Revenue Market Share by Regions in 2021

Figure 44. China Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Tuberculosis Vaccines Sales Market Share by Country in 2021

Figure 51. Europe Tuberculosis Vaccines Revenue Market Share by Country in 2021

Figure 52. Germany Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Tuberculosis Vaccines Revenue Market Share by Country in 2021

Figure 59. Egypt Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Tuberculosis Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Tuberculosis Vaccines in 2021

Figure 65. Manufacturing Process Analysis of Tuberculosis Vaccines

Figure 66. Industry Chain Structure of Tuberculosis Vaccines

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles